<DOC>
	<DOCNO>NCT00815906</DOCNO>
	<brief_summary>The purpose study evaluate safety tolerability single dose SBI-087 Japanese subject rheumatoid arthritis .</brief_summary>
	<brief_title>Study Evaluating Single Doses Of SBI-087 In Japanese Subjects With Rheumatoid Arthritis</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<criteria>Must meet American College Rheumatology criterion rheumatoid arthritis functional class I III . Rheumatoid arthritis disease onset &gt; 16 year age duration disease least 6 month . Men woman nonchildbearing potential ( WONCBP ) , age 20 70 year , inclusive screen visit . Any significant health problem rheumatoid arthritis . Treatment great 10 mg prednisone per day . Therapy immunosuppressant within 6 month study day 1</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>June 2012</verification_date>
</DOC>